Tempus AI, Inc. TEM Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Clinical Order | $239.3M-2.7% | $245.9M+4.5% | $235.4M+6.2% | $221.7M+22.1% | $181.5M+66.4% | |
| Genomics Product | $21.8M— | —— | $252.9M+4.6% | $241.8M+1,866% | $12.3M— | |
| Insights Product | $71.3M-13.0% | $82M+18.8% | $69M+20.6% | $57.2M+15.6% | $49.5M-23.5% | |
| Next Product | $5.7M— | —— | —— | —— | $2.7M— | |
| Trials Product | $9.9M+1.0% | $9.8M+6.5% | $9.2M-6.1% | $9.8M+1.0% | $9.7M-8.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Tempus AI, Inc. break its business down?
- Tempus AI, Inc. (TEM) reports revenue by product across 6 parts — AI Applications, Clinical Order, Genomics Product, Insights Product and Next Product. Each is extracted from the segment footnotes and tracked over time.
- Where does Tempus AI, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Tempus AI, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
